RARRES2 and neoplasm: Notably, inhibiting chemerin actions through neutralization, small interfering RNA (siRNA) knockdown, or ChemR23 antagonism (CCX832) reduces invasion in both Boyden chamber and organotypic models, underscoring chemerin’s direct role in promoting tumor aggressiveness [33].